BUDAPEST, Hungary and ATLANTA, June 18, 2019 /PRNewswire/ -- Intrexon Corporation (Int...查看全文
越炒股越美2019-03-06 17:38
【Top6医药股盘点:XON上涨21.26%,涨幅最大】
$Intrexon(XON)$ $Bionano Genomics(BNGO)$$Anavex Life Sciences(AVXL)$ 3月5日涨幅最大的医药股分别是:生物技术公司 Intrexon Corporation 上涨21.26%;生命科学仪器公司Bionano上涨19.32% ;Anavex 生命科学公司上涨13.90等。 查看全文https:...查看全文
Just-a-Novice2018-02-23 13:14
The biggest challenge for tiny companies without successful history is visibility-----you struggle to distinguish speculation and solid judgements with reliable casual link; you struggle to judge if a claimed groundbreaking technology/product is really good or not; and you st...查看全文
$Intrexon(XON)$ 内部交易: 2019-05-20,CEO,KIRK RANDAL J ,买入,452502普通股, $4.63
$Intrexon(XON)$ 内部交易: 2019-05-17,CEO,KIRK RANDAL J ,买入,90794普通股, $4.69
$Intrexon(XON)$ 内部交易: 2019-05-21,CEO,KIRK RANDAL J ,买入,60223普通股, $4.74
$Intrexon(XON)$ 内部交易: 2019-05-20,CEO,KIRK RANDAL J ,买入,301670普通股, $4.63
$Intrexon(XON)$ 内部交易: 2019-05-17,CEO,KIRK RANDAL J ,买入,60530普通股, $4.69
$Intrexon(XON)$ SC 13D/A [Amend] - General statement of acquisition of beneficial ownership Filed: 2019-05-15 AccNo: 0001567619-19-011319 Size: 311 KB 网页链接
$Intrexon(XON)$ 内部交易: 2019-05-15,CEO,KIRK RANDAL J ,买入,471077普通股, $4.59
$Intrexon(XON)$ 内部交易: 2019-05-14,CEO,KIRK RANDAL J ,买入,221251普通股, $4.37
$Intrexon(XON)$ 内部交易: 2019-05-13,CEO,KIRK RANDAL J ,买入,565399普通股, $4.25
$Intrexon(XON)$ 内部交易: 2019-05-15,CEO,KIRK RANDAL J ,买入,314050普通股, $4.59